Likes Received$Hims & Hers Health(HIMS.US) is pushing ahead with weight-loss drugs despite such significant legal risks, which strongly suggests that its other business segments are performing poorly. Now it's been named in an FDA investigation and could be finished in the short term.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments